ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
THE FOLLOWING DISCUSSION OF THE RESULTS OF OUR OPERATIONS AND FINANCIAL CONDITION SHOULD BE READ IN CONJUNCTION WITH OUR FINANCIAL STATEMENTS AND THE NOTES THERETO INCLUDED ELSEWHERE IN THIS REPORT.
This section of the report includes a number of forward-looking statements that reflect the Company’s current views with respect to future events and financial performance. Forward-looking statements are often identified by words like: "believe," "expect," "estimate," "anticipate," "intend," "project" and similar
8
expressions, or words which, by their nature, refer to future events. You should not place undue certainty on these forward-looking statements, which apply only as of the date of this annual report. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical results or our predictions.
The following discussion provides an analysis of the results of our operations, an overview of our liquidity and capital resources and other items related to our business. The following discussion and analysis should be read in conjunction with our unaudited consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and our audited financial statements and notes included in our Annual Report on Form 10-K as of and for the year ended December 31, 2017.
Overview
Company references herein are referring to consolidated information pertaining to Incoming, Inc., the registrant.
The following discussion is an overview of the important factors that management focuses on in evaluating our businesses, financial condition and operating performance and should be read in conjunction with the financial statements included in this Quarterly Report on Form 10-Q. This discussion contains forward-looking statements that involve risks and uncertainties. Actual results could differ materially from those anticipated in these forward looking statements as a result of any number of factors, including those set forth in this Quarterly Report and elsewhere in the Company’s Annual Report on Form 10-K and other public filings.
All written and oral forward-looking statements made in connection with this Quarterly Report on Form 10-Q that are attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. Given the uncertainties that surround such statements, you are cautioned not to place undue reliance on such forward-looking statements.
Company Overview
NABE has historically been a refiner and producer of commercial-grade biodiesel as specified by the American Society of Testing and Materials (ASTM D6751). Our refining and production facility is located in Lenoir, North Carolina with a nameplate annual capacity of five million gallons. The Lenoir plant is currently idle due to adverse market conditions. Our facility has the ability to produce biodiesel from virgin, agri-based feedstock using commercial specifications. The biodiesel we produce is sold throughout North Carolina, South Carolina and Virginia directly or through wholesale distributors. At times, we have strategically purchased biodiesel from other producers to meet commercial requirements. We also purify and sell glycerin, which is created as a byproduct of the biodiesel production process. Once the facility has accumulated sufficient glycerin to make full loads, it is typically sold to the market.
Our production process starts with purchasing the most cost effective and suitable agri-based feedstock (e.g., soy, canola, sunflower, cotton seed and chicken/pork fat). A sample of every feedstock is tested by our in-house laboratory in order to develop the proper recipe of catalysts for the transesterification process. The glycerin byproduct is then separated from the biodiesel and any excess methanol is recovered. Recovered methanol is either sold or reused in the production process. Glycerin is sold on the open market as either a crude product or as a further-processed tech grade product. While biodiesel is our main product, glycerin is a popular chemical used in pharmaceutical and hygiene applications and serves as an additional source of revenue.
9
Our facility is capable of producing biodiesel from a wide range of agri-based feedstocks: soy, canola, sunflower, cotton seed and chicken/pork fat. Biodiesel production costs are highly dependent on the cost of feedstock, and we believe the ability to utilize a variety of feedstocks efficiently and interchangeably is imperative to gaining a competitive advantage in the biodiesel production market.
Results of Operations
The following is a discussion and analysis of our results of operations for the three and six-month periods ended June 30, 2018 and 2017, and the factors that could affect our future financial condition. This discussion and analysis should be read in conjunction with our financial statements and the notes thereto included elsewhere in this report. Our financial statements are prepared in accordance with United States generally accepted accounting principles. All references to dollar amounts in this section are in United States dollars unless expressly stated otherwise.
Revenue and Revenue From Related Parties
The Company generated no revenues during the period April 1, 2018 through June 30, 2018.
The Company generated revenues of $2,904 during the period April 1, 2017 through June 30, 2017.
Revenue generated during the period was solely due to sales of diluted methanol to third parties.
Comparing the Company’s activity for the period April 1, 2018 through June 30, 2018 to the activity for the period April 1, 2017 through June 30, 2017, there was a decrease in revenue of $2,904 from $2,904 to zero. The period-over-period decrease was primarily due to inactivity at the biodiesel production in Lenoir, NC during the second quarter. Depressed benchmark (petroleum) prices, high raw material costs and expiration of the blender tax credit have severely hampered the biodiesel market. Diluted methanol sales totaled $2,904 in the second quarter of 2017 while there were no sales in second quarter of 2018.
The Company generated no revenues during the period January 1, 2018 through June 30, 2018.
The Company generated revenues of $71,035 during the period January 1, 2017 through June 30, 2017. Revenue generated during the period was due to sales of biodiesel, kerosene, de-methylated glycerin, and recovered methanol. Third-party transactions during the first two quarters of 2017 included biodiesel sales totaling $43, diluted methanol sales of $2,904 de-methylated glycerin sales of $2,775, and recovered methanol sales of $658. Related party kerosene sales totaled $64,655 during the period under consideration.
Comparing the Company’s activity for the period January 1, 2018 through June 30, 2018 to the activity for the period January 1, 2017 through June 30, 2017, there was a decrease in revenue of $71,035 from $71,035 to zero. The period-over-period decrease was primarily due to sale of kerosene to a related party that occurred during the first half of the prior year. NABE started leveraging its existing operating licenses to sell kerosene during the last quarter of 2016. Kerosene sales totaled $64,655 during the first half of 2017, but there were no kerosene sales during the same period in 2018. Biodiesel sales totaled $43 in the first half of 2017 but were no sales during the same period in 2018. De-methylated glycerin sales totaled $2,775 during the first half of 2017 compared with no sales of the recovered product during the first six months of 2018. Methanol sales (diluted and recovered) were $3,562 in the first half of 2017 while there were none in the same period for 2018.
Cost of Revenue
10
Cost of revenue totaled $9,677 during the period April 1, 2018 through June 30, 2018. For the same period, cost of revenue consisted of costs associated with salaries, overhead, and utilities.
Cost of revenue totaled $19,499 during the period April 1, 2017 through June 30, 2017. For the same period, cost of revenue consisted of costs associated with raw material sales, labor, overhead, and utilities.
Comparing the Company’s activity for the period April 1, 2018 through June 30, 2018 to the activity for the period April 1, 2017 through June 30, 2017, there was a decrease in cost of revenues of $9,822 from $19,499 to $9,677. The period-over-period decrease was in line with reduced production activity and also affected by operating with fewer personnel at the biodiesel facility in Lenoir, NC.
Cost of revenue totaled $24,732 during the period January 1, 2018 through June 30, 2018. For the same period, cost of revenue consisted of costs associated with salaries, overhead, and utilities.
Cost of revenue totaled $118,763 during the period January 1, 2017 through June 30, 2017. For the same period, cost of revenue consisted of costs associated with kerosene purchases, labor, overhead, and utilities.
Comparing the Company’s activity for the period January 1, 2018 through June 30, 2018 to the activity for the period January 1, 2017 through June 30, 2017, there was a decrease in cost of revenues of $94,031 from $118,763 to $24,732. The period-over-period decrease was reflective of the Company’s inability to sell kerosene during the current year. During the first half of 2017, the Company purchased and re-sold kerosene. There were no kerosene purchases flowing through cost of sales since there were no sales during the first half of 2018.
Gross Loss
The Company had a gross loss of $17,841 for the period April 1, 2018 through June 30, 2018. The primary reason for the gross loss during the period was the Company’s inability to produce and sell biodiesel under adverse market conditions.
The Company had a gross loss of $33,398 for the period April 1, 2017 through June 30, 2017. The primary reason for the gross loss during the period was the Company’s inability to produce and sell biodiesel under adverse market conditions, including lower petroleum benchmark prices.
The Company had a gross loss of $40,970 for the period January 1, 2018 through June 30, 2018. The primary reason for the gross loss during the period was the Company’s inability to produce and sell biodiesel under adverse market conditions.
The Company had a gross loss of $81,410 for the period January 1, 2017 through June 30, 2017. The primary reason for the gross loss during the period was the Company’s inability to produce and sell biodiesel under adverse market conditions, including lower petroleum benchmark prices.
Selling, General and Administrative (SG&A) Expenses
SG&A expenses totaled $18,535 for the period April 1, 2018 through June 30, 2018. During the period under consideration, SG&A expenses primarily consisted of costs associated with payroll, office overhead and professional fees.
SG&A expenses totaled $19,228 for the period April 1, 2017 through June 30, 2017. During the period under consideration, SG&A expenses primarily consisted of costs associated with payroll, office overhead and professional fees.
11
Comparing the Company’s activity for the period April 1, 2018 through June 30, 2018 to the activity for the period April 1, 2017 through June 30, 2017, there was a decrease in SG&A expenses of $693 as SG&A declined from $19,228 to $18,535. The period-over-period decrease is related to reduced staffing costs considering the second quarter of the current year compared with the second quarter of the prior year.
SG&A expenses totaled $31,502 for the period January 1, 2018 through June 30, 2018. During the period under consideration, SG&A expenses primarily consisted of costs associated with payroll, office overhead and professional fees.
SG&A expenses totaled $36,421 for the period January 1, 2017 through June 30, 2017. During the period under consideration, SG&A expenses primarily consisted of costs associated with payroll, office overhead and professional fees.
Comparing the Company’s activity for the period January 1, 2018 through June 30, 2018 to the activity for the period January 1, 2017 through June 30, 2017, there was a decrease in SG&A expenses of $4,919 as SG&A declined from $36,421 to $31,502. The period-over-period decrease is related to reduced staffing costs considering the first half of the current year compared with the first half of the prior year.
Other Income (Expense)
The Company had no Other Income during the period April 1, 2018 through June 30, 2018.
Other Income totaled $47 during the period April 1, 2017 through June 30, 2017. During the second quarter of 2017, this amount was attributable to funding received from the USDA Biofuel Program. Each quarter, the Company submits a Payment Request (Form RD-4288) and supporting documents to the USDA delineating those gallons produced/sold. Along with the documentation, the Company informs the USDA regarding the type and quantity of feedstocks utilized. These payment requests are reviewed by an agent of the USDA and then submitted as part of the “pool” for funding. Biodiesel producers compete for whatever funding is available from the USDA’s pool. Since it is difficult to predict the amount of funding that may be received, the Company only recognizes Other Income associated with the USDA Biofuel Program when the funds are received.
The Company had no Other Income during the period January 1, 2018 through June 30, 2018.
Other Income totaled $202 during the period January 1, 2017 through June 30, 2017. During the first six months of 2017, this amount was attributable to funding received from the USDA Biofuel Program.
Liquidity and Capital Resources
Working Capital
|
|
|
As of
June 30, 2018
|
|
As of
December 31, 2017
|
|
Current Assets
|
$
|
908
|
$
|
7,929
|
|
Current Liabilities
|
$
|
748,489
|
$
|
699,206
|
|
Working Capital Deficiency
|
$
|
(747,581)
|
$
|
(691,277)
|
|
Accumulated Deficit
|
$
|
(7,007,989)
|
$
|
(6,935,447)
|
12
Cash Flows
|
|
|
Six Months
Ended
June 30, 2018
|
|
Six Months
Ended
June 30, 2017
|
|
Cash used in operating activities
|
$
|
(60,960)
|
$
|
(48,043)
|
|
Cash provided by investing activities
|
|
-
|
|
14,271
|
|
Cash provided by financing activities
|
|
57,760
|
|
25,563
|
|
Net (decrease) in cash
|
$
|
(3,200)
|
$
|
(8,209)
|
As of June 30, 2018, our current assets totaling $908 consisted of cash, accounts receivable, and other current assets. Our accounts payable and accrued liabilities and current portion of amounts due to related parties and third parties were $748,489 as of June 30, 2018. As a result, we had a working capital deficiency of $747,581.
Current assets for the Company totaled $7,929 as of December 31, 2017. Current liabilities for the Company totaled $699,206 as of December 31, 2017, which resulted in a working capital deficiency of $691,277.
Comparing the working capital deficiency at June 30, 2018 to the deficiency at December 31, 2017, there was an increase of $56,304 as the deficiency increased from $691,277 to $747,581. The biggest contributor to the overall increase was the Company’s reduced production activity. Production activity was negatively impacted by lower petrodiesel (benchmark) market prices, and due to relatively higher feedstock prices.
On a short-term basis, it is anticipated that the Company’s liquidity needs will be met through selling biodiesel related products and RIN-gallons, through borrowing from related parties and through the sale of common stock. Considering the long-term view, the Company intends to provide liquidity through operation of its biodiesel plant in Lenoir, North Carolina. Since the December 31, 2017 balance sheet date, no amounts of receivables were written off.
To date, cash flow requirements have been primarily met through sales of biodiesel related products, through collections of accounts receivable, through share issuances, and through gross proceeds from bank and related party loans. Management expects to keep operational costs to a minimum until cash is available through financing or operating activities. Management plans to continue to seek other sources of financing on favorable terms; however, there are no assurances that any such financing can be obtained on favorable terms, if at all. For the six months ended June 30, 2018, the Company generated a gross loss of $40,970 on no sales over the same period. For the six months ended June 30, 2017, the Company generated a gross loss of $81,410 on sales of $71,035 over the same period.
A portion of the Company’s operations have been funded through the issuance of common stock shares. As of June 30, 2018, the Company has issued 33,754,332 shares of common stock (31,774,332 shares of Class A stock and 1,980,000 shares of Class B stock).
Cash Used In Operating Activities
During the period January 1, 2018 through June 30, 2018, the Company’s cash used in operating activities totaled $60,960. For the same period, the Company’s cash used in operating activities was primarily attributable to amortizing prepaid insurance and to making payments on trade payables. Insurance amortization totaled $3,821 while payables decreased $8,433 during the first six months of 2018. Depreciation expense was $16,238 for the first six months of 2018.
13
During the period January 1, 2017 through June 30, 2017, the Company’s cash used in operating activities totaled $48,043. For the same period, the Company’s cash used in operating activities was primarily attributable to collecting trade receivables associated with kerosene sales, and to making transactions on trade payables. Third party trade receivables decreased $9,578 while inventories decreased $13,787. Third party trade payables and accrued expenses increased $3,684 and $5,801, respectively, for the same period. Related party payables decreased $31,154 due to a reclassification of trade payables to notes payable (see Cash Provided By Financing Activities below). Depreciation expense was $33,682 for the first six months of 2017.
Cash Provided By Investing Activities
During the period January 1, 2018 through June 30, 2018, the Company had no cash flow related to investing activities.
During the period January 1, 2017 through June 30, 2017, the Company’s cash flows provided by investing activities totaled $14,271. Cash provided by investing activity resulted from the sale of equipment comprising the diesel exhaust fluid (DEF) production system. The equipment was sold to a third party at book value, therefore, no gain or loss was recorded on the sale.
Cash Provided By Financing Activities
During the period January 1, 2018 through June 30, 2018, the Company’s cash provided by to financing activities totaled $57,760. This amount represents proceeds provided from short-term financing from a related party, net of payments on short-term debt.
During the period January 1, 2017 through June 30, 2017, the Company’s cash flow related to financing activities totaled $25,563. This amount represents proceeds provided from short-term financing from a related party during the period under consideration. At December 31, 2016, the Company recognized a related party payable totaling $31,154. This amount was reclassified as a note payable during the prior year.
Future Financings
We anticipate that additional funding will be required in the form of equity financing from the sale of our common stock in order to proceed with our acquisition and expansion plan. However, we cannot provide investors with any assurance that we will be able to raise sufficient funding from the sale of our common stock to fund our marketing and acquisition plans. At this time, we do not have any arrangements in place for any future equity financing.
Off-Balance Sheet Arrangements
We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.
Recent Accounting Pronouncements
Management does not expect any financial statement impact from any recently-issued pronouncements.